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The objective of this study, on the one hand, is to evaluate the impact of Candida Albicans infection (10 6 CFU per 0.2 
ml of intravenous inoculum) on the biochemical and hematological approaches of adult Wistar rats, on the other hand, 
to test the efficacy of Syzygium aromaticum essential oil (CEO) in restoring or not the harmful effects of the studied 
yeast with a daily intraperitoneal injection of 0.1 ml CEO/kg. The extraction of the essential oil from S.aromaticum by 
hydro-distillation allowed us to obtain CEO with a yield of 10.18%. Infection of adult rats with Candida albicans by 
intravenous injection at a concentration of 106 CFU per 0.2 ml of inoculum increased hepatic and renal fungal load. The 
infection also revealed a disruption of various biochemical parameters, including liver (AST, ALT), kidney (urea, 
creatinine) biochemical assays, and hematological (white and red blood cells, platelets...); also, the results show a 
correction in the values of these parameters following the administration of CEO (by an intraperitoneal injection of 0.1 
ml CEO/kg/day) compared to those of infected animals. CEO also corrected the shape of the affected blood cells after 
infection with C. albicans. 
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INTRODUCTION 
Fungi are a fundamental cause of human infection, and yeasts of the Candida genus 
are the most pathogenic fungi (Moran et al., 2012). Candida albicans is an 
opportunistic yeast that usually inhabits the human body (mouth, throat, intestines, and 
genitourinary tract). It is generally considered a normal part of the human commensal 
flora (Kohler and al., 2020; Mayer and al., 2013). C.albicans is responsible for several 
types of infections that can be divided into two groups: Mucosal candidiasis and 
systemic or disseminated candidiasis, which are the most severe diseases (Drummond 
and Brown, 2011). It can switch from the commensal to the parasitic state, causing 
respiratory, digestive and/or vaginal infections (Naglik and al., 2014; Sdoudi and al., 
2014). 
Herbal medicines have been documented as an essential source for discovering new 
pharmaceutical molecules used to treat serious illnesses. Many plant species would 
have pharmacological activities attributable to their phytoconstituents, such as 
glycosides, saponins, flavonoids, steroids, tannins, alkaloids, terpenes (Batiha and al., 
2020). In the same way, green chemistry adopts in its principles all the necessary 
precautions for the protection of humans and the environment based on green 
 
 
extraction technologies (Mnayer, 2014). Clove (Syzygium aromaticum) is used for its culinary and medicinal virtues. Since 
then, other properties have been discovered, such as an anti-inflammatory, antibacterial, and antianaphylactic and 
anticandidal effect (Adli et al., 2018; Yassin et al., 2020). Thus, the influential role of cloves as inhibitors of various 
degenerative diseases is attributed to diverse chemical constituents in high concentrations with antioxidant activity (Astuti 
et al., 2019; Batiha et al., 2020). Chromatographic analyses of Syzygium aromaticum essential oils identified 26 compounds 
which mainly represent approximately 80.83% eugenol, 10.48% eugenol acetate, 7.21% β caryophyllene (Adli et al. 2017). 
In the light of these studies, our goal is to investigate the effect of the essential oil of the Syzygium aromaticum plant on 
Candida albicans infection in adult Wistar rats, according to biochemical and hematological approaches. 
 
MATERIALS AND METHODS 
Extraction of the essential oil 
The researcher realized the present study using the Syzygium aromaticum (clove), a plant) imported from Indonesia 
(the Moluccan Island). This plant is widely used in Algeria because of its importance in the Algerian culinary tradition, 
and its use as an herbal medicine. The plant is available at market all year. 
The dry and ripe seeds of Syzygium aromaticum were purchased from the local herb market in Saida (Algeria) and were 
identified and authenticated by an expert taxonomist. A voucher specimen code P-200676 was deposited at the herbarium 
of the Department of Biology at Saida University (Algeria). The part of the plant used to extract the essential oil is the 
flower buds of S.aromaticum. The extraction of essential oil has been done by hydro-distillation 
 
Yield Calculation 
The yield of essential oil (EO) is the ratio between the weight of the extracted oil and the weight of the plant material 
used (Hajammar and al., 2009; Adli and al., 2017). It is calculated as a percentage by the following formula: Y (%) = (M1 
/M0) ×100 
Y: essential oil yield. 
M1: quantity of oil extracted expressed in grams (g); M0: quantity of dry matter used for extraction expressed in grams 
(g). 
Preparation of the fungal inoculum: 
In a sterile tube containing sterile saline solution, we have placed colonies of our fungal strain “Candida albicans ATCC 
10231" and mixed the suspension. Then using the Malassez cell (Faurie 2019), we prepared a microbial suspension that 
contains 10 6 CFU (Colony Forming Unit) of C. albicans (Chilar and Calderone 2009; Lionakis 2010; Liu et al. 2011). 
Experimental Design: 
Experiments were carried out on adult Wistar rats, seven months old (obtained from the Department of Biology, Faculty 
of Sciences, University of Saida) weighing 210±50 g. The animals were housed with free access to water and food in an 
animal room, with a 12/12-hour light/dark cycle, at 22 ± 2 °C. The rats were divided into four groups (n=7 rats): infected 
(Ca), infected treated with clove essential oil (Ca+EO), control-vehicle (Control), control treated with clove essential oil 
(Control+EO). The number and suffering of animals were minimized by the guidelines of the European Union Directive 
(2010/63/EU). 
Group Ca: The rats were infected with 106 CFU per 0.2ml of inoculum of the Candida albicans; by intravenous 
injection into the caudal vein in the tail (Chilar and Calderone 2009; Lionakis 2010; Liu et al. 2011). 
Group Ca+EO: After 24 hours of infection, infected rats were treated with 0.1ml/kg of Syzygium aromaticum essential 
oil for eight days intraperitoneally (Adli et al.2018). 
Group Control: Rats drinking distilled water. 
Group Control+EO: Rats receiving distilled water were treated with 0.1 ml/kg of Syzygium aromaticum essential oil 
for 08 days intraperitoneally (Adli et al., 2018). 
Infected rats were observed three times a day to monitor any infection's signs and temperature fluctuations. 
At the end of the experiment the animals were sacrificed after 12 hours (morning fast), by IP injection with a solution of 
chloral (C2H3C13O2) to 10%.  After incision of the abdomen, blood is collected by cardiac puncture in heparin tubes for 
biochemical analysis and EDTA and tubes for hematological evaluation and dry tubes for blood smears. 
 
Determination of tissue fungal load 
To evaluate the effect of infection induced by C. Albicans in adult rats, we determined the fungal tissue load in blood, 
liver, and kidney using the method of Cihlaret al. (2009). 
 
Biochemical assay 
CRP (C-reactive protein) 
The CRP assay was done using a kit (Biomaghreb). The CRP level was determined according to the method of Dieusaert 
(2015). 
 
 Determination of the kidney and liver parameters  
The concentrations of kidney markers activities, urea, and creatinine were measured using kits (Chronolab, Spain) 
according to Kaplan (1984), and creatinine was according to Murray (1984). 
The serum samples were used to measure the activity of alanine aminotransferase (ALT), aspartate aminotransferase (AST) 
according to the methods of Reitman et al. (1957).  
 
Hematological Assay 
 Determination of hematological parameters 
Blood taken with EDTA was used for the determination of total red blood cells (RBCs), packed cell volume (PCV), 
hemoglobin (Hb), mean cell volume (MCV), mean corpuscular hemoglobin (MCH), and platelets count using an automatic 
cell counter  (Mindray BC 3000 plus).   
Statistical Analysis  
Results were expressed as mean ± standard error of the mean (SEM). Data were analyzed by the two-way analyses of 
variance (ANOVAs).  When a significant difference was found, the StudentNewman-Keuls posthoc test was conducted. 
For all analyses, a difference was considered significant at p ≤ 0.05. 
 
RESULTS AND DISCUSSIONS    
 The hydro-distillation technique enabled the CEO to be obtained with a yield of 10.18%. This result is not similar to 
the results of Wenqiang et al. (2006). Who reported a yield of 11.50%, this difference in yield could be attributed to many 
factors, essentially the origin, the species, the harvest period, the drying time, and the extraction technique of the essential 
oils (Karousou et al., 2005). 
The clinical signs of candidemia or systemic candidiasis are identical to those that characterize episodes of bacteremia 
and are therefore not specific at all (Bone et al., 1992). There is no specific symptomatology for fungemia and systemic 
Candida spp. Infections. Fever is observed in approximately 80% of cases (Develoux et al. 2005; Guery et al., 2009). The 
liver synthesizes C-reactive protein (CRP) during acute or chronic inflammation in the body.  Its level in the blood rises 
before the onset of inflammation and falls rapidly once the inflammation is treated (Thiébaux, 2019). Besides, its 
sensitivity, specificity, and short half-life are of significant interest in diagnosing and monitoring infectious diseases 
(Bouadel, 2010). 
 During the experiment, we measured the temperature and followed its evolution daily. The results show that the infected 
rats with C.albicans had a fluctuating temperature, where there was a significant increase during the first 1 st day, 2 nd, 
4th, 6th, and 7th. The day after infection compared to control rats (p<0.001; p<0.001, p<0.001, p<0.001, p<0.01, 
p<0.001respectively). Otherwise, we recorded a significant decrease in temperature in infected treated rats with CEO 
compared to infected rats during the 4 th, 6 th, and 7 th day (p<0.001, p<0.001,p<0.001 respectively) (Figure 1), in contrast, 
Wu and al. (2019) revealed that a single injection of 25,000 viable C.albicans cells in mice, which is a low-grade transient 




Figure 1. Temperature evolution of control, infected with C. albicans and infected treated rats 
 
Besides, the CRP assay was positive in the early days of infection, confirming that an inflammatory process started 
after we injected Candida albicans into the adult rats. Administration of CEO in Candida albicans infected rats resulted in 
a significant decrease in temperature compared to infected rats; also, CRP was negative in infected CEO-treated rats 
compared to non-treated infected rats, which could be explained by the antipyretic, anti-inflammatory, and antifungal effect 
of the essential oil of S.aromaticum (Batiha and al., 2020; Han and Parker, 2017). Pinto et al. (2009) put forward the 
potential of the CEO as a therapeutic option for fungal infections in humans.  Clove has fungicidal characteristics in vitro 
and in vivo due to its phenolic components, carvacrol and Eugenol (Pulikottil et al., 2015).  Clove EO is fungicidal at low 
concentrations to fluconazole-resistant strains of human pathogenic yeast, such as Candida spp (Lobstein et al., 2017). 
Pulikottil et al. (2015). indicated that the antifungal activity is due to a considerable reduction in the amount of ergosterol, 
a specific component of the fungal cell membrane, and it is the action of Eugenol where it attacks the biofilms of C.albicans. 
Our results concerning the determination of the fungal tissue load showed that at blood level, the fungal load in rats 
after 2 days of their C.albicans infection (first sacrifice) is higher than after the other days (second sacrifice, third and 




Figure 2. The tissue fungal load in blood in C. albicans infected and infected and CEO-treated rats. 
 
 Candida albicans are present in infected rats' liver from the second day of infection (first sacrifice) (96.25 CFU/g). The 
fungal load increased significantly (p<0.001) until it reached the highest value after 7 days of C. Albicans infection (third 
sacrifice) (17.26×102 CFU/g), then it decreased significantly (p<0.001) after 9 days of infection (fourth sacrifice) (9.5×102 
CFU/g) (Figure 3), and persisted in rising in the kidneys after the 9 the days of infection (Figure 4).  
 
 

























































Figure 4: The renal fungal load in C. albicans infected rats and infected and CEO-treated rats. 
Lionakis et al. (2010) found that intravenous injection of Candida in mice induced a rapid elimination of 99% of the 
fungus from the bloodstream, dissemination to all organs tested within 1 hour after injection, and the initial fungal load in 
the kidneys and brain increased. Even between the kidney and the brain, a distinct pattern was apparent; the fungal load in 
the brain peaked on Day 4 and decreased on Day 7, while the renal fungal load continued to increase. Liu et al. (2011) 
found that after intravenous injection of Candida albicans, the fungal tissue load was first increased in the brain and liver 
and then decreased throughout the experiment, whereas it was increased in the kidneys throughout. The spectrum of yeast 
infections due to Candida yeasts is vast, and practically all organs can be affected (Eggimann et al., 2003; Spellerg et al., 
2005). Studies by Louria and al (1963) in mice show that renal infection appears to be related to the penetration and growth 
of the renal tubular lumen. Besides, the inflammatory response in the kidney appeared 4 hours later than in other tissues. 
The cellular and molecular factors that determine the organ-specific differential control of Candida are still mostly 
unknown (Lionakis and al, 2010). The cytoskeleton-like organization of hyphae creates a rigid structure whose growth 
generates forces capable of crossing normal tissues and cell barriers (Defranco et al., 2015). The pathogenesis of Candida 
albicans comes from its ability to switch from a yeast form to a hyphal form where the yeast form can spread effortlessly 
through the blood while the hyphal form facilitates tissue invasion (Defranco et al., 2015).  
Also, CEO administration showed a difference in the hepatic and renal fungal load where we noticed a significant 
decrease in fungal load in infected rats treated with CEO compared to infected rats. The antifungal activity of the CEO 
may justify this. S. aromaticum has definite antifungal activity against C. Albicans (Mansourian et al., 2014; Yassin et al., 
2020). Eugenol has also been reported to reduce adhesion, biofilm formation, and even alter the morphogenesis of C. 
Albicans (De Paula et al., 2014). Eugenol has been shown to decrease cell viability significantly, and its fungicidal mode 
of action against C. Albicans may be related to its ability to disrupt cell wall integrity by increasing cell permeability, 
leading to cell leakage (Khan et al., 2013; Shabir et al., 2020). 
Urea and creatinine are particular biochemical markers used in the diagnosis of kidney function (Saleh et al., 2012).  In 
kidney dysfunction, urea and creatinine will be secreted in abundance in the blood (Nwanjo et al., 2005) because of their 
accumulation in the kidney. Rats infected with C. Albicans had significantly elevated (P < 0.001) uremia and serum 
creatinine throughout the experiment compared to control rats (Figure 5 and Figure 6). 
   
  
Figure 5. Plasma urea levels in rats: controls, treated 
controls, C.albicans infected and infected treated with 
CEO. Values are expressed as mean ± SEM: ***: 
P˂0.001, *: P˂0.05. 
Figure 6. Comparison of creatinemia concentration 
between rats: controls, treated controls, C. albicans 
infected and infected treated with CEO. Values are 








































Shin et al.  (2014) reported an increase in urea and creatinine levels in mice infected with a pathogenic strain of 
C.albicans (SC5314) (106CFU) that resulted in renal dysfunction and chronic renal failure. Renal lesions were evaluated 
in mice following systemic administration of C.albicans (Shin et al., 2014). Mice were inoculated intravenously with 
graduated doses of Candida albicans, and observations were made on mortality. The study showed an increase in urea and 
creatinine levels (Ryley and al., 1988). The principal cause of mortality from C.albicans infection is candidiasis 
disseminated by fungal growth in the kidneys and kidney damage (Parker and al., 1976). 
On the other hand, after treatment with CEO in infected rats, a decrease in urea and creatinine was noted. The efficacy 
of CEO in the kidneys may have been due to the presence of chelating compounds such as eugenol (Nassar et al., 2007; 
Said et al., 2011).  Studies suggest that cloves improve kidney function and correct dysfunction in chronic kidney disease 
(Luvuno et al., 2016). Said et al. (2011) also showed that Eugenol reduces gentamicin-induced tubular necrosis in the 
kidneys and offers protection against renal failure by acting as an antioxidant. 
The liver is an organ that plays an essential role in maintaining the body's homeostasis (Denen and al., 2015).  
Transaminases (ASATs and ALATs) are sensitive intracellular enzymes and biomarkers secreted into the bloodstream 
following hepatocyte damage and necrosis (Udenze and al., 2012). Liver damage can be assessed by measuring 
transaminase activity (ASAT and ALAT) (Bai and al., 2012). We noted that serum transaminase levels (ASAT and ALAT) 
were significantly increased (P <0.001) in C. Albicans infected rats compared to controls (Figure 7 and Figure 8).   
  
Figure 7. Comparison of serum transaminase levels 
(ASAT) in rats: controls, treated controls, infected with 
C. albicans and infected treated with CEO. Values are 
expressed as mean ± SEM: ***: P˂0.001 
Figure 8. Comparison of serum transaminase (ALAT) 
levels in rats: controls, treated controls, infected with 
C.albicans and infected treated with CEO. Values are 
expressed as mean ± SEM: ***: P˂0.001. 
Cardinale et al. (2001) showed that candidiasis causes liver damage with an increase in transaminases.  Fungal infection 
of the liver is usually due to Candida spp (Fiore et al., 2018). Also, there was a significant decrease in liver parameters 
following CEO administration in infected rats than untreated infected rats.  These results are concordant with those of Anbu 
et al. (2012), who reported that Eugenol decreases plasma transaminases. In rats with hepatic dysfunction, daily intake of 
CEO or an EO-containing emulsion of cloves or a microemulsion of Eugenol improved these symptoms in all cases (Al-
okbi et al., 2014).  
We observed a significant increase in the hematological parameters studied: white blood cells (WBCs), red blood cells 
(RBCs), hemoglobin (HGB), Mean platelet volume (MPV), platelets (PLT), hematocrit (HCT), Mean hemoglobin content 
(MHC) showed a significant increase in the number of WBCs in infected rats compared to control rats (P<0.001)(Table 1).  
Table 1. Comparison of hematological parameters between rats: controls, treated controls, C. albicans infected and 
infected treated with CEO. 
 Control Control+EO Ca Ca+EO 
WBCs.103/µl 7.08±0.02 5.40±0.58 10.70±0.12*** 7.45±0.10*** 
RBCs.106/µl 7.53±0.01 7.23±0.01 8.19±0.44 7.88±0.56 
HGB g/dl 12.95±0.03 13.15±0.14 14.90±0.52** 13.15±0.55** 
MPV Fl 7.05±0.03 6.85±0.03 6.65±0.14** 7.00±0.04** 
PLT.103/µl 451.50±0.87 745.00±26.56*** 835.00±1.15*** 544.50±2.6*** 
HCT % 39.25±0.10 39.90±0.87 44.65±1.07** 40.55±1.93* 
MHC pg 16.93±0.05 16.85±0.03 16.60±0.57 16.55±0.09 











































Blood is a complex of microorganisms and a hostile environment composed of several cell types and immunoreactive 
molecules to which C.albicans must adapt and respond (Fradin et al., 2005). Blood cells significantly influence the pattern 
of C.albicans gene expression in the blood (Fradin et al., 2003). Individual inflammatory responses have evolved to combat 
fungi that grow along epithelial surfaces.  Careful dissection of allergic mucosal inflammatory responses has revealed that 
the characteristic granulocytes (eosinophils), cytokines (interleukin IL-5 and IL- 13), and T effector cells (T helper type 2 
(Th2) cells; Th17) are potent fungicides or at least necessary for optimal fungal clearance at mucosal sites in vivo (Porter 
et al. 2011). Candida expresses adhesions and surface mannoproteins that activate alternative pathways and complement 
lectins, leading to opsonization and phagocytosis by neutrophils and macrophages.   Phagocytosis triggers the assembly 
of NADPH oxidase and the production of reactive oxygen intermediates, catalyzed by myeloperoxidase (MPO) (De franco 
et al., 2015).  Interactions of fungal cell wall components such as mannoproteins and B-glucan, with phagocyte receptors, 
facilitate attachment and stimulate cytokine release.  The production of cytokines by neutrophil activities, coupled with 
direct interactions of neutrophils with tissue dendritic cells, triggers the acquired immune response (De franco et al., 2015). 
 Normal human neutrophils (38 studies) killed 29.0± 7.4% of C. Albicans ingested in 1 hour.  Eosinophils and monocytes 
killed a lower percentage (Lehrer et al., 1969). Iron is an essential element for the growth of Candida. Indeed, as in any 
living cell, iron and other heavy metals are essential growth factors in fungi.  An iron overload has been described during 
bacterial but also fungal infections.  Indeed, most fungi (Candida, Aspergillus, Mucor) secrete siderophores, low molecular 
weight compounds with a very high affinity for iron ions (Cardinale et al., 2001). The essential oil of Syzygium aromaticum 
decreased the values of hematological parameters in rats infected with C.albicans, and it significantly corrected the 
deformation caused by this yeast.  CEO reduces inflammation phenomena by inhibiting tumor necrosis factor (TNF) and 
prostaglandin E2 (PGE2) production and by modulating the action of cyclooxygenase 2 (Cox-2) (Sung et al., 2012; 
Bachiega et al., 2012). The anti-inflammatory effects of Eugenol have been attributed to its effect in preventing 
neutrophil/macrophage chemotaxis and prostaglandin synthesis as well as cyclooxygenase II enzyme expression (Pei et al., 
2009; Batiha et al., 2020). The antifungal effect of Eugenol and clove oil has been studied against yeasts and filamentous 
fungi, including various human pathogenic fungi and foodborne fungal species (Chaieb et al., 2007). 
 
CONCLUSIONS 
Our study revealed that infection of adult Wistar rats with Candida albicans caused biochemical and hematological 
alterations.  In addition, our data showed that Syzygium aromaticum essential oil could restore these damages. 
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